In 2020, the American Diabetes Association’s 80th Scientific Sessions was a virtual conference...
PromarkerD at AMCP Nexus
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney disease, exhibited at the Academy of Managed Care Pharmacy Nexus (AMCP Nexus 2021), an in-person conference in Denver, Colorado from the 18th – 21st of October.
The Company presented a PromarkerD clinical utility study as a poster abstract. Poster available here.
Clinical utility study to add to the weight of evidence supporting a US reimbursement code application for PromarkerD.
PromarkerD can predict DKD up to 4 years in advance. A simple test measures 3 plasma biomarkers and 3 clinical factors.